[Indometacin glucosamide in the therapy of rheumatoid arthritis (author's transl)].

Abstract

40 patients with classical or definite rheumatoid arthritis were included in a double blind trial to assess efficacy and side effects of indometacin (n = 20) versus glucametacin (n = 20). In a daily dose of 420 mg glucametacin proved to be equally potent to 150 mg indometacin daily in its anti-inflammatory activity but showed fewer side effects.

• Authors: K Chlud, B Kaik, S Pangerl
• Journal: Arzneimittel-Forschung (Arzneimittelforschung) Vol. 28 Issue 7 Pg. 1200-1 ( 1978) ISSN: 0004-4172 [Print] Germany
• Vernacular Title: Indometacin-glucosamid in der Behandlung der chronischen polyarthritis.
• PMID: 582710 (Publication Type: Clinical Trial, Controlled Clinical Trial, English Abstract, Journal Article)

Chemical References

• Indomethacin

Topics

• Arthritis, Rheumatoid (drug therapy)
• Double-Blind Method
• Female
• Humans
• Indomethacin (adverse effects, analogs & derivatives, therapeutic use)
• Male
• Middle Aged